The effects of pentoxifylline and tocopherol in jaw osteomyelitis
1
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Objectives: Pentoxifylline (PTX) is a methylxanthine derivative that has been implicated in the pathogenesis of peripheral vessel disease and inter-mittent lameness. The purpose of this study was to investigate the effect of PTX and tocopherol in patients diagnosed with osteoradionecrosis (ORN), bisphosphonate-related osteonecrosis of the jaw (BRONJ), and chronic osteomyelitis using digital panoramic radiographs. Materials and Methods: This study was performed in 25 patients who were prescribed PTX and tocopherol for treatment of ORN, BRONJ, and chronic osteomyelitis between January 2014 and May 2018 in Seoul National University Dental Hospital. Radiographic densities of the dental pan-orama were compared prior to starting PTX and tocopherol, at 3 months, and at 6 months after prescription. Radiographic densities were measured using Adobe Photoshop CS6 (Adobe System Inc., USA). Blood sample tests showing the degree of inflammation at the initial visit were considered the baseline and compared with results after 3 to 6 months. Statistical analysis was performed using the Mann–Whitney test and repeated measurement ANOVA using IBM SPSS 23.0 (IBM Corp., USA).Results: Eight patients were diagnosed with ORN, nine patients with BRONJ, and the other 8 patients with chronic osteomyelitis. Ten of the 25 patients were men, average age was 66.32±14.39 years, and average duration of medication was 151.8±80.65 days (range, 56-315 days). Statistically significant increases were observed in the changes between 3 and 6 months after prescription (P<0.05). There was no significant difference between ORN, BRONJ, and chronic osteomyelitis. Only erythrocyte sedimentation rate (ESR) was statistically significantly lower than before treatment (P<0.05) among the white blood cell (WBC), ESR, and absolute neutrophil count (ANC). Conclusion: Long-term use of PTX and tocopherol can be an auxiliary method in the treatment of ORN, BRONJ, or chronic osteomyelitis in jaw.
Abstract
Objectives: Pentoxifylline (PTX) is a methylxanthine derivative that has been implicated in the pathogenesis of peripheral vessel disease and inter-mittent lameness. The purpose of this study was to investigate the effect of PTX and tocopherol in patients diagnosed with osteoradionecrosis (ORN), bisphosphonate-related osteonecrosis of the jaw (BRONJ), and chronic osteomyelitis using digital panoramic radiographs. Materials and Methods: This study was performed in 25 patients who were prescribed PTX and tocopherol for treatment of ORN, BRONJ, and chronic osteomyelitis between January 2014 and May 2018 in Seoul National University Dental Hospital. Radiographic densities of the dental pan-orama were compared prior to starting PTX and tocopherol, at 3 months, and at 6 months after prescription. Radiographic densities were measured using Adobe Photoshop CS6 (Adobe System Inc., USA). Blood sample tests showing the degree of inflammation at the initial visit were considered the baseline and compared with results after 3 to 6 months. Statistical analysis was performed using the Mann–Whitney test and repeated measurement ANOVA using IBM SPSS 23.0 (IBM Corp., USA).Results: Eight patients were diagnosed with ORN, nine patients with BRONJ, and the other 8 patients with chronic osteomyelitis. Ten of the 25 patients were men, average age was 66.32±14.39 years, and average duration of medication was 151.8±80.65 days (range, 56-315 days). Statistically significant increases were observed in the changes between 3 and 6 months after prescription (P<0.05). There was no significant difference between ORN, BRONJ, and chronic osteomyelitis. Only erythrocyte sedimentation rate (ESR) was statistically significantly lower than before treatment (P<0.05) among the white blood cell (WBC), ESR, and absolute neutrophil count (ANC). Conclusion: Long-term use of PTX and tocopherol can be an auxiliary method in the treatment of ORN, BRONJ, or chronic osteomyelitis in jaw.
참고문헌 (24)
- Martos-Fernández M, "Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis : a systematic review", Oral Surg Oral Med Oral Pathol Oral Radiol, 125, pp.431~439 (2018)
- Ward A, "Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy", Drugs, 34, pp.50~97 (1987)
- Magnusson M, "Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans", Eur J Pharmacol, 581, pp.290~295 (2008)
- Neuner P, "Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells", Immunology, 83, pp.262~267 (1994)
- Lyons AJ, "Pentoxifylline : a review of its use in osteoradionecrosis", Br J Oral Maxillofac Surg, 55, pp.230~234 (2017)
- Delanian S, "Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol : a phase II trial", Head Neck, 27, pp.114~123 (2005)
- Delanian S, "Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination(PENTOCLO) : a phase II trial", Int J Radiat Oncol Biol Phys, 80, pp.832~839 (2011)
- Qaisi M, "Bone margin analysis for osteonecrosis and osteomyelitis of the jaws", Oral Maxillofac Surg Clin North Am, 29, pp.301~313 (2017)
- Notani K, "Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy", Head Neck, 25, pp.181~186 (2003)
- Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update", J Oral Maxillofac Surg, 72, pp.1938~1956 (2014)
- Ruggiero SL, "Diagnosis and staging of medication-related osteonecrosis of the jaw", Oral Maxillofac Surg Clin North Am, 27, pp.479~487 (2015)
- Futran ND, "Pentoxifylline in the treatment of radiation-related soft tissue injury : preliminary observations", Laryngoscope, 107, pp.391~395 (1997)
- Zhao Y, "Computed densitometry of panoramic radiographs in evaluation of bone healing after enucleation of mandibular odontogenic keratocysts", Chin J Dent Res, 13, pp.123~126 (2010)
- White SC, "Update on the biological effects of ionizing radiation, relative dose factors and radiation hygiene", Aust Dent J, 57(Suppl 1), pp.2~8 (2012)
- Mallya SM, "Imaging of radiation-and medicationrelated osteonecrosis", Radiol Clin North Am, 56, pp.77~89 (2018)
- Delanian S, "The radiation-induced fibroatrophic process : therapeutic perspective via the antioxidant pathway", Radiother Oncol, 73, pp.119~131 (2004)
- McLeod NM, "Pentoxifylline and tocopherol in the management of patients with osteoradionecrosis, the Portsmouth experience", Br J Oral Maxillofac Surg, 50, pp.41~44 (2012)
- D'Souza J, "Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible : experience from a regional head and neck unit", Br J Oral Maxillofac Surg, 52, pp.356~362 (2014)
- Epstein MS, "Management of bisphosphonate-associated osteonecrosis : pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 110, pp.593~596 (2010)
- Magremanne M, "Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid-related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis", J Oral Maxillofac Surg, 72, pp.334~337 (2014)
- Owosho AA, "Pentoxifylline and tocopherol in the management of cancer patients with medicationrelated osteonecrosis of the jaw: an observational retrospective study of initial case series", Oral Surg Oral Med Oral Pathol Oral Radiol, 122, pp.455~459 (2016)
- Boerma M, "Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol", Int J Radiat Oncol Biol Phys, 72, pp.170~177 (2008)
- Rübe CE, "Modulation of radiation-induced tumour necrosis factor alpha(TNF-alpha)expression in the lung tissue by pentoxifylline", Radiother Oncol, 64, pp.177~187 (2002)
- Delanian S, "Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis", J Clin Oncol, 23, pp.8570~8579 (2005)